Valuation: CEREP

Market Cap 86.76M 98.91M 80.1M 74.02M 140M 9.47B 143M 963M 374M 4.63B 371M 363M 16.09B P/E 2024 *
-
P/E 2025 -
Enterprise Value 65.72M 74.93M 60.68M 56.07M 106M 7.17B 108M 729M 283M 3.51B 281M 275M 12.19B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2024-04-10
Director TitleAgeSince
Chairman - 2023-08-10
Director/Board Member - 2024-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+4.98%+2.69%+9.14% 49.74B
-0.36%+1.21%+420.77%+619.10% 40.49B
-2.29%+3.83%+23.48%+59.26% 34.35B
-2.13%+0.29%+23.91%-6.01% 34.75B
-0.79%+2.02%+3.83%+36.42% 26.98B
+3.82%+3.51% - - 16.58B
-2.62%-2.13%+64.96%+125.87% 15.6B
-2.17%+6.65%+104.31%+102.15% 14.27B
-2.70%-2.04%+12.37%+18.19% 13.76B
Average -1.05%+2.57%+82.04%+120.52% 27.39B
Weighted average by Cap. -1.00%+2.96%+93.86%+139.18%

Financials

2024 2025
Net sales 40.49M 46.16M 37.38M 34.54M 65.47M 4.42B 66.78M 449M 175M 2.16B 173M 170M 7.51B 41.1M 46.86M 37.94M 35.06M 66.46M 4.49B 67.79M 456M 177M 2.2B 176M 172M 7.62B
Net income 7.15M 8.16M 6.61M 6.1M 11.57M 781M 11.8M 79.41M 30.85M 382M 30.63M 29.96M 1.33B 4.78M 5.45M 4.42M 4.08M 7.73M 522M 7.89M 53.08M 20.62M 255M 20.48M 20.03M 887M
Net Debt -17.25M -19.67M -15.93M -14.72M -27.9M -1.88B -28.46M -191M -74.4M -922M -73.87M -72.25M -3.2B -21.03M -23.98M -19.42M -17.95M -34.01M -2.3B -34.7M -233M -90.71M -1.12B -90.06M -88.09M -3.9B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-